Active pharmaceutical ingredient sourcing and production was the main theme of a recent webinar on supply chain resilience arranged by Medicines for Europe, where panellists discussed where API for European manufacturers comes from. Concerns for the security of European supply chain were evident as participants agreed that “India and China are actively outperforming European businesses.”
“Europe has lost its strong position as an API producer,” said Mundicare CEO Andreas Meiser, pointing out that Europe’s supply...